To view the PDF file, sign up for a MySharenet subscription.

CMP - Cipla Medpro South Africa Limited - Dealing in securities by a director of

Release Date: 28/11/2011 17:00
Code(s): CMP
Wrap Text

CMP - Cipla Medpro South Africa Limited - Dealing in securities by a director of a major subsidiary CIPLA MEDPRO SOUTH AFRICA LIMITED (Incorporated in the Republic of South Africa) (Registration number 2002/018027/06) (ISIN Number: ZAE000128179 Share Code: CMP) ("Cipla Medpro" or "the Company") DEALING IN SECURITIES BY A DIRECTOR OF A MAJOR SUBSIDIARY In terms of paragraph 3.63 - 3.65 of the JSE Limited Listings Requirements, the following information relates to the dealing in securities by a director of a major subsidiary of Cipla Medpro: Director: Mr JB van Staden Status: Executive director of a major subsidiary Office held: Director of a major subsidiary, Medpro Pharmaceutica (Pty) Ltd Date of transaction: 24 November 2011 Nature of transaction: Sale of shares Number of shares: 60 000 Price per share: R6.55 Total value of transaction: R393 000.00 Extent of interest: Direct, beneficial Nature of transaction: Sale of shares on the open market Written clearance to deal obtained: Yes Durban 28 November 2011 Sponsor Nedbank Capital Date: 28/11/2011 17:00:01 Supplied by www.sharenet.co.za Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited (`JSE`). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.

Share This Story